132992-29-1 Usage
Uses
Used in Pharmaceutical Industry:
2,3,5-Trifluorotoluene is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to enhance the properties of drug molecules, such as increasing their stability and bioavailability.
Used in Agrochemical Industry:
In the agrochemical sector, 2,3,5-trifluorotoluene is utilized as a precursor in the production of agrochemicals, contributing to the development of more effective and targeted pesticides and other agricultural chemicals.
Used as a Solvent in Chemical Processes:
2,3,5-Trifluorotoluene is employed as a solvent in a range of chemical processes due to its ability to dissolve a wide array of substances and facilitate various chemical reactions.
Used in Dye Manufacturing:
2,3,5-TRIFLUOROTOLUENE is used as a reagent in the manufacturing of dyes, where it contributes to the creation of dyes with specific color properties and improved performance characteristics.
Used in Resin and Plastics Production:
2,3,5-Trifluorotoluene is also utilized in the production of resins and plastics, where it helps in developing materials with enhanced properties, such as increased durability and resistance to environmental factors.
Check Digit Verification of cas no
The CAS Registry Mumber 132992-29-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,9,9 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 132992-29:
(8*1)+(7*3)+(6*2)+(5*9)+(4*9)+(3*2)+(2*2)+(1*9)=141
141 % 10 = 1
So 132992-29-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H5F3/c1-4-2-5(8)3-6(9)7(4)10/h2-3H,1H3
132992-29-1Relevant academic research and scientific papers
Isothiazole derivatives useful as anticancer agents
-
, (2008/06/13)
The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X1, R1, R2and R3are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods treating hyperproliferative disorders in mammals by administering the above compounds.
